Health Systems Trust Better Health for all in Southern Africa

Home     News     Publications    Health Statistics    Programmes     Search


News
HST collects relevant news from a variety of sources, for your convenience and thus has no control over the content of these news articles. Select a story from below, or use our search feature to find stories of interest.





 

 

 

AZT study finds no evidence of cardiac damage in infants
Kaiser Daily HIV report
2000-09-15

Despite concerns that zidovudine, or AZT, may be associated with cardiac mitochondrial dysfunction in infants when the drug is used to prevent mother-to-child transmission of HIV, research based on data from NIH's National Heart, Lung, and Blood Institute found no evidence of such cardiac dysfunction in infants exposed to the drug in the perinatal period.

Despite concerns that zidovudine, or AZT, may be associated with cardiac mitochondrial dysfunction in infants when the drug is used to prevent mother-to-child transmission of HIV, research based on data from NIH's National Heart, Lung, and Blood Institute found no evidence of such cardiac dysfunction in infants exposed to the drug in the perinatal period.

The study, led by Dr. Steven Lipshultz and published in the Sept. 14 issue of the New England Journal of Medicine, monitored a group of infants born to HIV-infected women from birth to age five, performing echocardiographic studies every four to six months. Echocardiograms were used to detect certain abnormalities in the left ventricle, which would indicate mitochondrial cardiomyopathy, the condition previous studies found to be present among infants exposed to AZT.

The team does acknowledge weaknesses in their own study, however, saying "the samples in our study are too small to provide an accurate estimate of the frequency of an uncommon toxic effect. Also, the small number of infants exposed to [AZT] who were followed after 14 months of age is likely to be inadequate for us to detect late-emerging events." Researchers conclude that "the benefits of [AZT] during pregnancy in reducing vertical transmission of HIV outweigh the reported cardiac risks. ... Any decision not to initiate [AZT] therapy, or to stop it, should be made with great caution."
(Source: Kaiser Daily HIV/AIDS report, 14/9/00)


Keywords This Item is associated with the Following Keywords: .
   
You Can Comment on this Item, or View other people's Comments
 

 

Related News

 
Mother-to-child transmission may be more common with subtype D than A (2005-08-19)
Treating HIV-positive children with antiretrovirals in first two months increases AIDS free survival (2005-05-20)
AZT and nevirapine after birth reduce HIV transmission (2003-10-16)
Combination Therapy Might Be Better Choice Than Nevirapine Alone To Prevent Vertical HIV Transmission, Researchers Say (2005-02-28)
WHO publishes new guidelines on preventing mother to child transmission of HIV (2004-08-06)
 

 Related Publications

 
Infant Feeding Practices in KwaZulu-Natal - An exploratory study of current infant feeding practices of mothers with 0-6 month old infants attending PMTCT and non-PMTCT clinics in Central Durban (2004-02-11)
National Guide to Monitoring and Evaluating Programmes for the Prevention of HIV in Infants and Young Children (2004-10-26)
Counselling on infant feeding choice: Some practical realities from South Africa (2007-01-10)
Monitoring Methodology used in the Khayelitsha mother-to-child HIV transmission prevention program (2001-07-04)
Bacterial Contamination and Nutrient Concentration of Infant Milk in South Africa:A Sub-study of the National PMTCT Cohort Study (2003-10-07)
 

Related Health Statistics

 
Vitamin A coverage infants 6-11 months (2005-06-06)
Waist-hip ratio (WHR) above cut-off (%) (2004-05-19)
Percentage of facilities that are PMTCT sites (2004-05-14)
Percentage provider knowledge of correct drug treatment of STI syndromes (2004-05-14)
Proportion of population with sustainable access to an improved water source (2005-09-07)
 

Related Events

 
Third Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infant (2001-09-09)
Invitation to the launch of The Cholera Outbreak report (2002-03-25)
24th African Health Sciences Congress (2003-09-28)
Academy of Pharmaceutical Sciences 24th Annual Congress (2003-10-07)
Evaluating educational interventions for HIV/AIDS (2001-05-01)
 

Related links

 
Perinatal Education Programme (PEP)
Women, Children and HIV
The Perinatal Education Programme (PEP)
MedScape DrugInfo
Evidence-Based Medicine
 

Related Content

 
Prevention of Mother-to-Child Transmission of HIV/AIDS (PMTCT) (2004-04-07)
The HIV Impulse Project (2004-04-07)
Summary Bulletin 8 - DHS-LG Discussion List (2004-07-16)
The Research Cluster (2004-02-09)
Treatment Monitor: Treatment as part of a continuum of care (2007-07-11)
 

   
 

 Contact details       Terms of use       Funder info